Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00189683 | Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 19, 2005source: clinicaltrials